BioSpace News Archive

REVA Medical, LLC, a leader in bioresorbable polymer technologies for vascular applications, announced that enrollment in the MOTIV pivotal trial has been initiated at clinical centers in both the U.S. and Europe.

Zentalis™ Pharmaceuticals, Inc. today announced the promotion of co-founder Kevin Bunker, Ph.D., to Chief Scientific Officer.

BIOQUAL’s Board of Directors has declared a dividend of $1.00 per share for shareholders of record on October 6, 2022, payable on October 27, 2022.

4D Molecular Therapeutics, Inc. announced the appointment of Noriyuki (‘Nori’) Kasahara, MD, PhD to the Board of Directors.

Gamida Cell Ltd., the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, announced the launch of a follow-on public offering of its ordinary shares.

Aytu BioPharma, Inc., a pharmaceutical company focused on commercializing novel therapeutics, with a development pipeline addressing rare, pediatric-onset disorders, announced financial and operational results for the fourth quarter and fiscal year ended June 30, 2022.

BD, a leading global medical technology company, officially opened the BD Innovation Center in collaboration with University of Maryland BioPark, offering University of Maryland, Baltimore students and researchers access to state-of-the-art equipment to support and accelerate innovation in medical diagnostic technology.

Precision Optics Corporation, Inc. announced operating results on an unaudited basis for its fourth quarter and fiscal year.

The U.S. Food and Drug Administration (FDA) has granted approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to aid in selection of patients with RET -fusion positive locally advanced or metastatic non-small cell lung cancer (NSCLC).

During a special event, The Feinstein Institutes for Medical Research, the research home of Northwell Health, and Governor Kathy Hochul announced the completion of a $35 million, 20,000-square-foot renovation project meant to energize future breakthroughs in bioelectronic medicine.